Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial

Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial

Nayoung Han,1,* Su Hyun Hong,1,2,* Yon Su Kim,3 Dong Ki Kim,3 In-Wha Kim,1 Eunhee Ji,4 Jung Mi Oh1 1Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 2Pharmaceutical Standardization Division, Drug Evaluation Department, National Institute of Food...

Full description

Bibliographic Details
Main Authors: Han N, Hong SH, Kim YS, Kim DK, Kim IW, Ji E, Oh JM
Format: Article
Language:English
Published: Dove Medical Press 2017-08-01
Series:Therapeutics and Clinical Risk Management
Subjects:
fibroblast growth factor-23
vitamin D deficiency
calcium carbonate
calcitriol
mineral and bone disorder
chronic kidney disease
Online Access:https://www.dovepress.com/effect-of-additive-calcium-administration-on-fgf23-levels-in-patients--peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/effect-of-additive-calcium-administration-on-fgf23-levels-in-patients--peer-reviewed-article-TCRM

Similar Items